Literature DB >> 10547431

Cellular immune responses of pigs induced by vaccination with either a whole cell sonicate or pepsin-digested Brachyspira (Serpulina) hyodysenteriae bacterin.

W R Waters1, B A Pesch, R Hontecillas, R E Sacco, F A Zuckermann, M J Wannemuehler.   

Abstract

Brachyspira (Serpulina) hyodysenteriae infection of pigs (swine dysentery) causes a mucohemorrhagic diarrhea resulting in significant economic losses for producers. A commercial vaccine consisting of a proteinase-digested bacterin has shown efficacy in the reduction of disease due to B. hyodysenteriae. Vaccines consisting of whole cell bacterins, however, generally fail to protect pigs from disease. In the present study, cellular immune responses induced by a proteinase-digested bacterin were compared to responses induced by a whole cell sonicate antigen preparation. In addition, usage of either squalene or Freund's incomplete adjuvants in combination with each antigen preparation was also compared. Both antigen preparations induced significant cellular immune responses as measured by in vitro (IFN-gamma production and T cell proliferation) and in vivo methods (DTH responses). No significant differences were detected in proliferative, interferon-gamma (IFN-gamma), or delayed type hypersensitivity (DTH) responses by pigs receiving either adjuvant or antigen preparation. T cells (CD3(+)) but not B cells from vaccinated animals proliferated in response to in vitro stimulation with B. hyodysenteriae antigen. CD8(+) (single positive and CD4/CD8 double positive) and gammadelta(+) T cells were particularly responsive. In addition, high percentages of both CD8 single positive and CD4/CD8 double positive cells were detected in antigen-stimulated cultures. These findings demonstrate the unique sensitivity of porcine CD8(+) T cells to priming for recall response by vaccination with a proteinase-digested B. hyodysenteriae bacterin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547431     DOI: 10.1016/s0264-410x(99)00266-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  CD4+ T-cell responses and distribution at the colonic mucosa during Brachyspira hyodysenteriae-induced colitis in pigs.

Authors:  Raquel Hontecillas; Josep Bassaganya-Riera; Jennifer Wilson; David L Hutto; Michael J Wannemuehler
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  Antigen-specific proliferation of porcine CD8alphaalpha cells to an extracellular bacterial pathogen.

Authors:  W R Waters; R Hontecillas; R E Sacco; F A Zuckermann; K R Harkins; J Bassaganya-Riera; M J Wannemuehler
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  Ganglioside GM3 inhibits proliferation and invasion of glioma.

Authors:  Yasunori Fujimoto; Shuichi Izumoto; Tsuyoshi Suzuki; Manabu Kinoshita; Naoki Kagawa; Kouichi Wada; Naoya Hashimoto; Motohiko Maruno; Yuji Nakatsuji; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

4.  Consecutive pathological and immunological alterations during experimentally induced swine dysentery - a study performed by repeated endoscopy and biopsy samplings through an intestinal cannula.

Authors:  M Jacobson; R Lindberg; R Jonasson; C Fellström; M Jensen Waern
Journal:  Res Vet Sci       Date:  2006-10-04       Impact factor: 2.534

5.  Sodium sulfite (SoS) as decontamination strategy for Fusarium-toxin contaminated maize and its impact on immunological traits in pigs challenged with lipopolysaccharide (LPS).

Authors:  Anh-Tuan Tran; Jeannette Kluess; Susanne Kersten; Andreas Berk; Marleen Paulick; Dian Schatzmayr; Sven Dänicke; Jana Frahm
Journal:  Mycotoxin Res       Date:  2020-09-09       Impact factor: 3.833

6.  An avirulent Brachyspira hyodysenteriae strain elicits intestinal IgA and slows down spread of swine dysentery.

Authors:  Maxime Mahu; Filip Boyen; Stefano Canessa; Jackeline Zavala Marchan; Freddy Haesebrouck; An Martel; Frank Pasmans
Journal:  Vet Res       Date:  2017-10-05       Impact factor: 3.683

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.